pillbase.ru

Yervoy

Active substance: ipilimumab

Ipilimumab

Centralised EU authorisationActive

Marketing holder: Bristol-Myers Squibb Pharma EEIG

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
RU 2
  • Ервой®
    концентрат для приготовления раствора для инфузий, 5 мг/мл, 10.7 мл (original in Russian, GRLS)
    ЛП-№(000196)-(РГ-RU)
    Бристол-Майерс Сквибб Компани
  • Ервой®
    концентрат для приготовления раствора для инфузий, 5 мг/мл, 10.7 мл (original in Russian, GRLS)
    ЛП-003609
    Бристол-Майерс Сквибб Компани
US 2
  • YERVOY
    INJECTION · IPILIMUMAB 5 mg/mL
    0003-2328
    E.R. Squibb & Sons, L.L.C.
  • YERVOY
    INJECTION · IPILIMUMAB 5 mg/mL
    0003-2327
    E.R. Squibb & Sons, L.L.C.
Import and control

Control by country

  • Russiaprescription only

    Source: GRLS (Russian state register) · record 01a120c3-350d-7f40-93d9-451bff0ca3c3,01a120c5-1961-7d1e-b1bf-c7fe55e991e3;count=2 · valid from 2026-10-09 · verified 2026-10-09

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-4ca5-7ce9-937a-aae8393f879b,01a12093-48b6-701f-8eec-9c5efb781fb4;count=2 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/002213
Registration status
Active
ATC code
L01FX04
Sources
  • product · EMA · EMEA/H/C/002213 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/002213 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/002213 · Verified 2026-10-09